Pharmacovigilance of vaccines;Pharmacovigilance des vaccins

Archives de Pediatrie

Volumn 13, Issue 2, 2006, Pages 175-180

  Autret Leca, E ^a   Bensouda Grimaldi, L ^a   Jonville Bera A P ^a   Beau Salinas, F ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Adverse drug reaction reporting systems; Product surveillance, post marketing; Vaccines, adverse effects

Indexed keywords

ALUMINUM HYDROXIDE; GELATIN; HEPATITIS B VACCINE; LATEX; MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE; NEOMYCIN; PNEUMOCOCCUS VACCINE; VACCINE;

ADVERSE DRUG REACTION; ALLERGIC REACTION; ASEPTIC MENINGITIS; AUTISM; CROHN DISEASE; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EGG; FASCIITIS; HUMAN; MULTIPLE SCLEROSIS; PHARMACOEPIDEMIOLOGY; POSTMARKETING SURVEILLANCE; REVIEW;

EID: 31944439063     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2005.10.020     Document Type: Short Survey

References (43)

1. Décret du 24 mai 1984 (JO du 30/5/1984) Livre V du Code de la Santé publique (articles R5144-1 et R5144-11). Décret 95/278 du 13 mars 1995. D́cret 95-566 du 6 mai 1995.
2. M. Aymard Ḿthodologie d'́valuation des vaccins viraux Th́rapie 51 1996 439 443
3. B. Begaud, J.C. Evreux, and J. Jouglard Imputabilit́ des effets inattendus ou toxiques des ḿdicaments Th́rapie 40 1985 111 118
4. G.S. Giebink The prevention of pneumococcal disease in children N. Engl. J. Med. 345 2001 1177 1183
5. J.M. Musser, and S.L. Kaplan Pneumococcal research transformed N. Engl. J. Med. 345 2001 1206 1207
6. B. Soubeyrand Toĺrance des vaccins:: faits et sṕculations Med. Mal. Infect. 33 2003 287 299
7. A.P. Jonville-B́ra, E. Autret, and C. Galy-Eyraud Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance Centres and by the firm Pasteur Ḿrieux Śrums et Vaccins Pharmacoepidemiol. Drug Saf. 5 1996 33 37
8. A.P. Jonville-B́ra, E. Autret, and C. Galy-Eyraud Thrombocytopenic purpura following measles, mumps and rubella vaccination Pediatr. Infec. Dis. J. 15 1996 44 48
9. A.P. Jonville-B́ra, E. Autret-Leca, and F. Barbeillon Sudden unexpected death in infants under 3:months of age and vaccination status -:a case-control study Br. J. Clin. Pharmacol. 51 2001 271 276
10. P.J. Fleming, P.S. Blair, and M.W. Platt The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study BMJ 322 2001 822 825
11. J.B. Classen, and D.C. Classen Association between type 1 diabetes and Hib vaccine. Causal relation is likely BMJ 319 1999 1133
12. H. White Association between type 1 diabetes and Hib vaccine. More research is still needed BMJ 319 1999 1133
13. M. Karvonen, Z. Cepaitis, and J. Tuomilehto Association between type 1 diabetes and haemophilus influenzae type b vaccination: birth cohort study BMJ 318 1999 1169 1172
14. A. Ascherio, S.M. Zhang, and M.A. Hernan Hepatitis B vaccination and the risk of multiple sclerosis N. Engl. J. Med. 344 2001 327 332
15. B. Begaud, and A. Alṕrovitch Vaccinations and multiple sclerosis N. Engl. J. Med. 344 2001 1793
16. C. Confavreux, S. Suissa, and P. Saddier Vaccinations and the risk of relapse in multiple sclerosis N. Engl. J. Med. 344 2001 319 326
17. M.A. Hernan, S.S. Jick, and M.J. Olek Recombinant hepatitis B vaccine and the risk of multiple sclerosis Neurology 63 2004 838 842
18. N.P. Thompson, S.M. Montgomery, and R.E. Pounder Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 345 1995 1071 1074
19. A.J. Wakefield, S.H. Murch, and A. Anthony Ileal-lymphoid-nodular hyperplasia, non specific colitis, and pervasive developmental disorder in children Retractation in Lancet 363 2004 750 (Lancet 1998; 351: 637-41)
20. V. Uhlmann, C.M. Martin, and O. Sheils Potential viral pathogenic mechanism for new variant inflammatory bowel disease Mol. Pathol. 55 2002 84 90
21. R.G. Pebody, M. Paunio, and P. Ruutu Measles, measles vaccination, and Crohn's disease Crohn's disease has not increased in Finland BMJ 316 1998 1745 1746
22. H. Peltola, A. Patja, and P. Leinikki No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study Lancet 351 1998 1327 1328
23. E. Miller, and P. Waight Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England BMJ 316 1998 1745
24. J.A. Kaye, M. del Mar Melero-Montes, and H. Jick Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis BMJ 322 2001 460 463
25. B. Taylor, E. Miller, and R. Lingam Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study BMJ 324 2002 393 396
26. L. Dales, S.J. Hammer, and N.J. Smith Time trends in autism and in MMR immunization coverage in California JAMA 285 2001 1183 1185
27. M. Feeney, A. Ciegg, and P. Winwood A case-control study of measles vaccination and inflammatory bowel disease Lancet 350 1997 764 766
28. J. Stephenson Vaccines pose no diabetes, bowel disease risk JAMA 284 2000 2307 2308
29. R.L. Davis, P. Kramarz, and K. Bohlke Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease Arch. Pedriatr. Adolesc. Med. 155 2001 354 359
30. K.M. Madsen, A. Hviid, and M. Vestergaard A population-based study of measles, mumps, and rubella vaccination and autism N. Engl. J. Med. 347 2002 1477 1482 (et 1473-4)
31. T. Jefferson, M. Rudin, and C. Di Pietrantonj Systematic review of the effects of pertussis vaccines in children Vaccine 21 2003 2003 2014
32. M. Ramsay Time to review policy on contraindications to vaccination Lancet 356 2000 1459 1460
33. P.E. Vermeer-de Bondt, J. Labadie, and H.C. Rumke Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study BMJ 316 1998 902 903
34. M.A. Uberall, K. Stehr, and J.D. Cherry Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda accellular pertussis component DTP (DtaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine Dev. Biol. Stand. 89 1997 83 89
35. N. Le Saux, N.J. Barrowman, and D.L. Moore Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT Pediatrics 112 2003 e348
36. A. Maitra, A. Sherriff, and M. Griffiths Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study BMJ 328 2004 925 926
37. M. Vestergaard, A. Hviid, and K.M. Madsen MMR vaccination and febrile seizures. Evaluation of susceptible subgroups and long-term prognosis JAMA 292 2004 351 357
38. W.E. Barlow, R.L. Davis, and J.W. Glasser The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine N. Engl. J. Med. 345 2001 656 661
39. M.C. McEllistrem, J. Adams, and E.O. Mason Epidemiology of acute otitis media caused by streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine J. Infect. Dis. 188 2003 1679 1684
40. R.K. Gherardi, M. Coquet, and P. Cherin Macrophagic myofasciitis: an emerging entity Lancet 352 1998 347 352
41. R.K. Gherardi Myofasciite ̀ macrophages et hydroxyde d'aluminium: vers la d́finition d'un syndrome des adjuvants Rev. Neurol. (Paris) 159 2003 162 164
42. C.A. Siegrist Les adjuvants vaccinaux et la myofasciite ̀ macrophages Arch. Ped. 12 2005 96 100
43. T. Jefferson, M. Rudin, and C. Di Pietrantonj Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence Lancet Infect. Dis. 4 2004 84 90